Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Truist??

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Oct 20, 2022 1:48pm

150 Views

Post# 35036916

RE:Truist??

A size buyer following the Trust meeting is good news even if there was a seller waiting to offload that stock.

barsax wrote: 50,000 shares @ $2 (12:05:58 (EDT))
226,000 shares @ $2 (1:23:14 (EDT))

so, virtually all of todays trading done in 2 trades 4x avg daily volume.

big buyer, big seller.